Study on Colon-Specific Delivery of Carboxymethylchitosan Microspheres Containing Levofloxacin

LI Yang,WANG Qiang,CHEN Han,QIAN Fang,SHEN Hong-liang,XU Wei-wei
DOI: https://doi.org/10.3321/j.issn:1003-3734.2007.24.017
2007-01-01
Abstract:Objective:To evaluate the colon-specific delivery of levofloxacin-carboxymethylchitosan microspheres(LVFX/CMC)in artificial medium and in rats.Methods:Microspheres were achieved by emulsification and cross-linking process.The in vitro release of microspheres in artificial alimentary juice was carried out with spectrophotometer and scanning electron microscopy.Sixty healthy male SD rats were divided randomly into 2 groups.One group received LVFX solution(40 mg,control group)and the other were treated with LVFX/CMC microspheres(40 mg,treatment group) by gastric lavage.HPLC was used to detect the concentrations of LVFX in the cecum and colon in both groups.Results:The accumulative release of LVFX/CMC microspheres was 8.62% in the artificial gastric juice for 2 h and 29.39% in the artificial small intestinal juice for 6 h,while the release reached to about 84.56% for LVFX/CMC microspheres in the artificial colon liquid for 4 h,and 93% for 24 h.The significant degradation of the LVFX/CMC microspheres was observed in the artificial colon liquid by SEM.At five and nine hours after administration,the levels of LVFX in cecum and colon were obviously higher in treatment group than those in control group.Conclusions:LVFX/CMC microspheres showed the potential of colon targeting property to release the levofloxacin in vitro and in rats.
What problem does this paper attempt to address?